Log in
Enquire now
‌

US Patent 10253369 Predicting likelihood of response to combination therapy

Patent 10253369 was granted and assigned to Biotheranostics on April, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Biotheranostics
Biotheranostics
0
Current Assignee
Biotheranostics
Biotheranostics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102533690
Patent Inventor Names
Yi Zhang0
Catherine Schnabel0
Mark G. Erlander0
Date of Patent
April 9, 2019
0
Patent Application Number
147247320
Date Filed
May 28, 2015
0
Patent Primary Examiner
‌
Stephanie K Mummert
0
Patent abstract

Provided are methods of determining whether a subject having ER+ breast cancer is expected to benefit from treatment with combination endocrine therapy and mTOR inhibitor therapy. Also provided are methods of treating a subject having ER+ breast cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10253369 Predicting likelihood of response to combination therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.